Broadview Heights, OH, United States of America

Vincent K Tuohy

This inventor holds 13 USPTO granted patents and 6 published patent applications and 3 EPO patents. Top assignees: The Cleveland Clinic Foundation, Other. Active years: 2015-2026.

USPTO Granted Patents = 13 

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.2

ph-index = 2

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2015-2026

Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: Vincent K. Tuohy: Innovator in Cancer Vaccine Development

Introduction

Vincent K. Tuohy is a prominent inventor based in Broadview Heights, OH (US), known for his groundbreaking work in the field of cancer immunotherapy. With a total of 11 patents to his name, Tuohy has made significant contributions to the development of vaccines aimed at treating and preventing various types of cancer.

Latest Patents

Among his latest patents, Tuohy has developed a breast cancer vaccine that comprises an immunogenic polypeptide featuring human α-lactalbumin. This innovative approach aims to provide a method for immunization against human breast cancer. Additionally, he has worked on ovarian cancer vaccines, which include methods, kits, and compositions designed to treat and prevent ovarian cancer by inducing an immune response against Anti-Mullerian Hormone Receptor, Type II (AMHR2).

Career Highlights

Tuohy has had a distinguished career, with notable affiliations including the Cleveland Clinic Foundation. His work has been instrumental in advancing the understanding and treatment of cancer through immunological approaches.

Collaborations

Throughout his career, Tuohy has collaborated with various professionals, including Justin M. Johnson and Ritika Jaini, contributing to the collective effort in cancer research and vaccine development.

Conclusion

Vincent K. Tuohy stands out as a leading inventor in the realm of cancer vaccines, with his innovative patents paving the way for new treatment options. His dedication to advancing cancer immunotherapy continues to inspire and impact the medical community.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…